X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

PHARMACOGENOMICS JOURNAL

期刊標題檢索 PHARMACOGENOMIC 最新評論: Has been demoted to Zone 3 (2021-02-07)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[PHARMACOGENOMICS JOURNAL]您好,您是該頁面的第 19035 位訪客。

期刊簡介
期刊名稱PHARMACOGENOMICS JOURNAL PHARMACOGENOMICS JOURNAL
LetPub Score
6.3
50 ratings
Rate

Reputation
7.6

Influence
5.1

Speed
7.0

期刊簡稱PHARMACOGENOMICS J
ISSN1470-269X
E-ISSN1473-1150
h-index78
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.200.6590.831
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Genetics
Q293 / 347
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Pharmacology
Q286 / 313
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Medicine
Q261 / 178

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
The Pharmacogenomics Journal is a print and electronic journal, which is dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications.

Key areas of coverage include:

Personalized medicine
Effects of genetic variability on drug toxicity and efficacy
Identification and functional characterization of polymorphisms relevant to drug action
Pharmacodynamic and pharmacokinetic variations and drug efficacy
Integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics
Clinical applications of genomic science
Identification of novel genomic targets for drug development
Potential benefits of pharmacogenomics.
官方網站https://www.nature.com/tpj
在線稿件提交https://mts-tpj.nature.com/
開放訪問No
出版商Springer Nature
主題領域医学
出版國/地區UNITED STATES
發行頻率四半期刊行
創刊年2001
每年文章數21每年文章數趨勢
黃金OA百分比29.73%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
GENETICS & HEREDITYSCIEQ281/191
PHARMACOLOGY & PHARMACYSCIEQ2147/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1470-269X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Ordinary
參考鏈接
相關期刊 【PHARMACOGENOMICS JOURNAL】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498329
    PHYTOMEDICINE340268
    LIFE SCIENCES285765
    International Journal of Pharmaceutics242440
    PHARMACOLOGICAL RESEARCH241282
    European Journal of Pharmacology204248
    BIOCHEMICAL PHARMACOLOGY202693
    JOURNAL OF NATURAL PRODUCTS196695
    BRITISH JOURNAL OF PHARMACOLOGY165141
    MOLECULAR PHARMACEUTICS162833
  •  

    PHARMACOGENOMICS JOURNAL PHARMACOGENOMICS JOURNAL
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [PHARMACOGENOMICS JOURNAL] 的評論撰寫評論
作者: 奉天俊强


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-02-07 13:49:53 評論於
Has been demoted to Zone 3
(0) 讚! | 奉天俊强

作者: 水月戊寅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-12-09 11:03:18 評論於
Review Speed: 10.0
Sharing Experience: This journal is extremely slow, the article was under review for nearly eight months before being sent for review, and only sent to one reviewer in the end. After revising, it was rejected, stating that the concept of the article was not new. Originally, it was just a small review, but being delayed for so long, even new concepts become old. This journal is a pit, hoping to help everyone avoid it. Of course, if you have plenty of time and don't mind at all, you can also try your luck
(0) 讚! | 水月戊寅

作者: Jane07


領域: 医学
審稿時間: 10.0 month(s)
結果: 拒稿


撰寫評論

2019-12-09 09:21:10 評論於
This journal was super dilatory. The article was kept for nearly eight months before being sent for review. In the end, it was sent to only one reviewer. After being revised, it was rejected, saying that the concepts of the article were not new. I intended to write a mini review. No matter how new the concepts were, they became old after being delayed for so long. I hope to help you avoid the incomprehensible journal. Of course, if you have a lot of time and don’t care at all, you can still have a try.

(0) 讚! | Jane07

作者: 是你的沛海呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-07-31 10:08:38 評論於
Could you please tell me if there have been any changes in the status? Or does "under consideration" mean the same as "under review"? Thank you
(0) 讚! | 是你的沛海呀

作者: 飞松mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-05-19 22:36:12 評論於
I am planning to invest in pharmacogenomics. Will it be very popular?
(0) 讚! | 飞松mio

作者: 玉女志敏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-04-23 19:24:23 評論於
Review speed: 6.0 | Submission success rate: 50.0
Experience sharing: Submitted on 2018-11-02, under consideration on 11-20, and status has not changed since then... The editorial office even sent an apology letter on 03-27... Cute
(0) 讚! | 玉女志敏

作者: 魔都锦玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-01-19 16:13:39 評論於
Submitted a meta-analysis for review over a month ago, but it was rejected
(0) 讚! | 魔都锦玉

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 21:09:43 評論於
Focused research direction: Genomics
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-02-26 22:09:15 評論於
It's not easy
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [PHARMACOGENOMICS JOURNAL] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*